Command Palette
Search for a command to run...
Biofil Chemicals
NSE: BIOFILCHEMBSE: 524396PHARMACEUTICALS & BIOTECHNOLOGYPHARMACEUTICALS
Market Cap
--
P/E Ratio
0.00
P/B Ratio
0.00
ROE
0.00%
ROA
0.00%
Debt/Equity
0.00
Book Value
₹0.0
EPS
₹0.0
About Biofil Chemicals
Biofil Chemicals & Pharmaceuticals is engaged in deals in manufacturing and trading of Pharmaceuticals. Further the company also deals in providing job work facility in respect of manufacturing of pharmaceuticals drug.
Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products. Later on, the Company was converted into a Public Limited Company on 7 May '92. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore. BCPL's new unit was set up at Pithampur in Madhya Pradesh at a project costing Rs 39.75 cr. The Company entered into business partnership with HLL Lifecare Limited (Formerly Hindustan Latex Ltd) an undertaking of Government of India. As per the agreed terms it provided manufacturing facility to HLL Lifecare Limited for manufacturing of Iron and Folic Acid Tablets (IFA) and other Pharmaceuticals products as required by HLL. Presently, the Company is flourishing business activates at Pithampur, in Madhya Pradesh. Now Company is not only dealing in the pharmaceutical product but has diversified its business activity in producing plastic products required for packing of pharmaceutical product and other plastic products.
Price Action • BIOFILCHEM
Financial Statements
Consolidated & Standalone Reports
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 45.67 | 33.71 | 40.52 | 30.13 | 22.53 | 36.55 | 29.86 | 23.23 | 12.46 | 13.59 | 13.7 | 6.32 |
Operating Expenses | 41.98 | 32.55 | 39.22 | 28.87 | 21.05 | 34.15 | 27.87 | 22.11 | 11.43 | 10.83 | 12.3 | 5.13 |
Operating Profit | 0.54 | 0.85 | 0.82 | 1.17 | 1.33 | 1.6 | 1.82 | 1.02 | 0.93 | 2.62 | 0.87 | 0.73 |
Operating Margin (%) | - | 2.51 | 2.01 | 3.87 | 5.91 | 4.38 | 6.1 | 4.4 | 7.5 | 19.27 | 6.35 | 11.6 |
Total Expenses | - | 32.97 | 39.66 | 29.34 | 21.52 | 34.63 | 28.4 | 22.63 | 11.87 | 11.28 | 12.72 | 5.59 |
EBITDA | - | 1.15 | 1.31 | 1.26 | 1.48 | 2.4 | 1.99 | 1.12 | 1.04 | 2.76 | 1.4 | 1.2 |
EBITDA Margin (%) | - | 3.42 | 3.22 | 4.2 | 6.58 | 6.56 | 6.68 | 4.84 | 8.31 | 20.29 | 10.2 | 18.91 |
Interest Expenses | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.07 | 0.12 | 0.16 | 0.15 | 0.16 | 0.15 | 0.21 |
Depreciation | 0.31 | 0.38 | 0.4 | 0.43 | 0.43 | 0.41 | 0.41 | 0.37 | 0.3 | 0.28 | 0.26 | 0.25 |
Profit Before Tax (PBT) | 3.35 | 0.74 | 0.87 | 0.79 | 1.01 | 1.92 | 1.46 | 0.6 | 0.59 | 2.31 | 0.98 | 0.74 |
Tax Expenses | 0.49 | 0.18 | 0.16 | 0.23 | 0.32 | 0.68 | 0.26 | 0.12 | 0.12 | 0.52 | 0.2 | 0.15 |
PAT Before Extraordinary Items | - | 0.56 | 0.71 | 0.56 | 0.7 | 1.24 | 1.21 | 0.48 | 0.47 | 1.79 | 0.78 | 0.59 |
Net Profit | 2.86 | 0.56 | 0.71 | 0.56 | 0.7 | 1.24 | 1.21 | 0.48 | 0.47 | 1.79 | 0.78 | 0.59 |
Net Profit Margin (%) | - | 1.66 | 1.77 | 1.86 | 3.12 | 3.47 | 4.06 | 2.08 | 3.8 | 13.33 | 5.94 | 10.01 |
EPS (Adjusted) | - | 0.34 | 0.44 | 0.34 | 0.43 | 0.76 | 0.74 | 0.3 | 0.29 | 1.1 | 0.48 | 0.36 |
Valuation & Key Ratios
Performance Metrics
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Book Value Per Share | - | 11.54 | 11.18 | 10.63 | 10.35 | 9.91 | 9.14 | 8.39 | 8.09 | 7.8 | 6.7 | 5.17 |
Return on Assets (ROA) % | - | 1.09 | 1.5 | 1.78 | 3.72 | 3.73 | 2.84 | 1.99 | 1.94 | 8.21 | 3.24 | 4.26 |
Return on Equity (ROE) % | - | 2.96 | 3.89 | 3.23 | 4.14 | 7.69 | 8.11 | 3.53 | 3.57 | 14.13 | 7.17 | 6.97 |
Return on Capital Employed (ROCE) % | - | 4.04 | 4.88 | 4.72 | 6.12 | 12.05 | 10.65 | 5.55 | 5.61 | 19.48 | 10.38 | 11.22 |
Profitability Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Liquidity Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Valuation Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Debt to Equity Ratio | - | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.08 | 0.12 | 0.12 | 0.11 | 0.13 | 0.35 |
Featured Insight
No recent news available
Key People
A
Apoorv Jain
Company Secretary,Compliance Officer
M
Mr. Pavan Singh Rajput
Chief Financial Officer